Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Synbiotic Approach to Immunity and Metabolism in the Elderly Study

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
Kiungo kimehifadhiwa kwenye clipboard
HaliImekamilika
Wadhamini
University of Roehampton

Maneno muhimu

Kikemikali

The aging process leads to a marked decline in immune function (immunosenescence), causing a significant reduction in immune response after vaccination or infections. Dietary intervention is an attractive, safe and non-invasive way to impact on gut bacteria and subsequently the functioning of the immune system. The ability of the dietary supplementation to alter these functions can be of particular importance in those groups that have an underdeveloped, poorly functioning immune system such as infants, immuno-compromised subjects or elderly. Research over the past two decades has provided evidence that administration of probiotics (live microorganisms which, when administered in adequate amounts, confer a health benefit on the host) could enhance immune function. Lactobacilli and bifidobacteria are the most common probiotics used in humans and various strains have been shown to have immunostimulatory properties in vitro and in experimental models, these properties include modulation of cytokine production. evidence exists of the immunostimulating effects of certain probiotics and the potential to use prebiotics to increase the levels of beneficial bacteria (which are known to be reduced in elderly population). Furthermore, by providing a probiotic at the same time as a prebiotic conditions for survival are enhanced. To date, only a small number of studies conducted have been randomised and/or placebo controlled to unequivocally demonstrate efficacies.

Maelezo

The aim of this study is to investigate the effect of probiotic Lactobacillus rhamnosus GG (commercialised as LGG), a pilus-less derivative L. rhamnosus GG (LGG-PB12)combined with a putative prebiotic PromitorTM (soluble corn fiber) i.e. a synbiotics and PromitorTM (SCF alone) on the faecal microbiota composition, metabolism and immunity in healthy individuals aged 60-80 years.

It consists of a 3 week randomised intervention treatment periods with the synbiotics, prebiotic and placebo control. Any adverse medical events which occur during the trial (e.g. headache, gut symptoms) should be recorded in a diary along with medication taken.

Tarehe

Imethibitishwa Mwisho: 04/30/2017
Iliyowasilishwa Kwanza: 05/10/2017
Uandikishaji uliokadiriwa Uliwasilishwa: 05/22/2017
Iliyotumwa Kwanza: 05/29/2017
Sasisho la Mwisho Liliwasilishwa: 05/22/2017
Sasisho la Mwisho Lilichapishwa: 05/29/2017
Tarehe halisi ya kuanza kwa masomo: 11/30/2013
Tarehe ya Kukamilisha Msingi iliyokadiriwa: 09/30/2014
Tarehe ya Kukamilisha Utafiti: 12/31/2014

Hali au ugonjwa

Healthy

Uingiliaji / matibabu

Dietary Supplement: LGG+Promitor™

Dietary Supplement: Promitor™

Dietary Supplement: LGG-PB12+Promitor™

Dietary Supplement: Maltodextrin

Awamu

-

Vikundi vya Arm

MkonoUingiliaji / matibabu
Experimental: LGG+Promitor™
LGG:10^12 CFU/g Lactobacillus rhamnosus GG (commercialised as LGG) combined with Promitor™:12g fibres/delivered of Soluble Corn Fibre (SCF) as dry powders to be consumed as 250 ml beverages at breakfast.
Dietary Supplement: LGG+Promitor™
synbiotic
Experimental: Promitor™
Promitor™:12g fibres/delivered of Soluble Corn Fibre (SCF) as dry powders to be consumed as 250 ml beverages at breakfast.
Dietary Supplement: Promitor™
Soluble Corn Fiber
Experimental: LGG-PB12+Promitor™
LGG-PB12:10^12 CFU/g of a pilus-less derivative L. rhamnosus GG combined with Promitor™:12g fibres/delivered of Soluble Corn Fibre (SCF) as dry powders to be consumed as 250 ml beverages at breakfast.
Dietary Supplement: LGG-PB12+Promitor™
synbiotic
Placebo Comparator: Maltodextrin
Maltodextrin (an oligosaccharide without prebiotic effect) 12g delivered and served as dry powders to be consumed as 250 ml beverages at breakfast.
Dietary Supplement: Maltodextrin
Control

Vigezo vya Kustahiki

Zama zinazostahiki Kujifunza 60 Years Kwa 60 Years
Jinsia Inastahiki KujifunzaAll
Hupokea Wajitolea wa AfyaNdio
Vigezo

Inclusion criteria:

- aged between 60 and 80 years of age.

- in good general health, defined as no comorbidities requiring regular medical follow up

- Ability to communicate well with the investigator and to comply with the requirements of the entire study

Exclusion criteria:

- History or evidence of organic disease of the gastrointestinal tract; such as tumour, irritable bowel syndrome, etc., within the previous 5 years

- Consumed probiotic or prebiotic preparations on a regular basis (at least 3 times per week) in the last 2 weeks and during the trial period

- Former participation in another study involving prebiotic or probiotic preparations or investigational drugs within the previous 6 months, or intention to use such drugs during the course of the study

- Undergone surgical resection of any part of the bowel

- History of malignancy within the previous 5 years (with exception of well-treated basal cell carcinoma or in situ cervical carcinoma).

- Currently prescribed immunosuppressive drugs

- Intention to use regularly other medication which affects gastrointestinal motility and/or perception

- Current or recent history (within 12 months) of significant drug or alcohol abuse or dependence

Matokeo

Hatua za Matokeo ya Msingi

1. The modulation of the gut microbiota by synbiotics and PromitorTM inflammatory/immune biomarkers [Changes from baseline to 21 days synbiotics and PromitorTM treatment]

Fecal16S rRNA amplicon sequencing to assess changes in fecal bacterial abundance and species diversity

Hatua za Matokeo ya Sekondari

1. The modulation of immune function by synbiotics and PromitorTM [Changes from baseline to 21 days synbiotics and PromitorTM treatment]

Blood samples analysis to assess changes in cytokines production

Hatua Nyingine za Matokeo

1. Digestive symptoms [Changes from baseline to 21 days synbiotics and PromitorTM treatment]

Bristol diary form

2. Microbiota activity (intestinal gas production) [Changes from baseline to 21 days synbiotics and PromitorTM treatment]

Intestinal gas evacuation on standardized diet

Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge